Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | FAP | Q12884 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3663764 | 0.87 | DPP4 (0.59) | DPP4 | |
| Hydrochloric Acid SCHEMBL18209332 | 0.86 | DPP4 (0.58) | DPP4 | |
| SCHEMBL4212805 | 0.82 | DPP4 (0.61) | DPP4CYP1A2CYP3A4CYP2D6KCNH2 | |
| SCHEMBL8774874 | 0.77 | DPP4 (0.77) | DPP4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL27964065 | 0.74 | DPP4 (0.86) | DPP4CYP1A2CYP3A4CYP2D6 | |
| Trelagliptin SCHEMBL175727 | 0.74 | DPP4 (1.00) | DPP4CYP1A2CYP3A4CYP2D6 | |
| Trelagliptin SCHEMBL29349599 | 0.74 | DPP4 (1.00) | DPP4CYP1A2CYP3A4CYP2D6 | |
| Trelagliptin SCHEMBL175726 | 0.74 | DPP4 (1.00) | DPP4CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6507784 | 0.74 | DPP4 (0.59) | DPP4KCNH2FAP | |
| SCHEMBL6511158 | 0.73 | DPP4 (0.56) | DPP4KCNH2FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2854772-A1 | SOLID PREPARATION | Takeda Pharmaceutical Company Limited (JP) | 2015-04-08 | — | — | EP | claimed |
| WO-2013183784-A1 | SOLID PREPARATION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-12-12 | — | — | WO | claimed |
| WO-2011005929-A1 | PIPERIDINE DERIVATIVE AND ITS USE FOR THE TREATMENT OF DIABETS AND OBESITY | ARENA PHARMACEUTICALS, INC. (US) | 2011-01-13 | — | — | WO | claimed |
| EP-2120885-A2 | SOLID PREPARATION COMPRISING 2-[[6-[(3R)-3-AMINO-1-PIPERIDINYL]-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL]METHYL]-4-FLUOROBENZONITRILE | Takeda Pharmaceutical Company Limited (JP) | 2009-11-25 | — | — | EP | claimed |
| WO-2008114800-A2 | SOLID PREPARATION COMPRISING 2- [ [6- [ (3R) -3-AMINO-1-PIPERIDINYL] -3, 4-DIHYDRO-3-METHYL-2, 4-DIOXO-1 (2H) -PYRIMIDINYL] METHYL] -4-FLUOROBENZONITRILE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-09-25 | — | — | WO | claimed |
| EP-2675774-A1 | PRODUCTION METHOD OF OPTICALLY ACTIVE DIHYDROBENZOFURAN DERIVATIVE | Takeda Pharmaceutical Company Limited (JP) | 2013-12-25 | — | — | EP | disclosed |
| WO-2012111849-A1 | PRODUCTION METHOD OF OPTICALLY ACTIVE DIHYDROBENZOFURAN DERIVATIVE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-08-23 | — | — | WO | disclosed |
| EP-2120885-A2 | SOLID PREPARATION COMPRISING 2-[[6-[(3R)-3-AMINO-1-PIPERIDINYL]-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL]METHYL]-4-FLUOROBENZONITRILE | Takeda Pharmaceutical Company Limited (JP) | 2009-11-25 | — | — | EP | disclosed |
| EP-2041123-A2 | FUSED CYCLIC COMPOUNDS | Takeda Pharmaceutical Company Limited (JP) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008114800-A2 | SOLID PREPARATION COMPRISING 2- [ [6- [ (3R) -3-AMINO-1-PIPERIDINYL] -3, 4-DIHYDRO-3-METHYL-2, 4-DIOXO-1 (2H) -PYRIMIDINYL] METHYL] -4-FLUOROBENZONITRILE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008001931-A2 | FUSED CYCLIC COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-01-03 | — | — | WO | disclosed |